Dionne
Welcome to the Dionne lab!
We are interested in (1) the effects of host genetics on the biology of infection; and (2) the physiological control of metabolic balance.
Host genetics and the biology of infection
Different individuals show different levels of resistance to infections and develop different pathologies in response to infections. We are interested in why this is the case. We use the fruitfly Drosophila melanogaster as a model host to study these questions; this allows us to screen for genes that affect the progress of infection in a rapid and unbiased fashion.
All of our experiments originate from a simple genetic screen. Mutant flies are infected with Mycobacterium marinum, a bacterium closely-related to the causative agent of tuberculosis, or with Mycobacterium smegmatis, a related non-pathogen. We select lines of flies that die more quickly or more slowly than wild-type controls and identify the mutation that gives rise to this phenotype. We then try to understand what this phenotype tells us about the function of the mutated gene.
So far, our work on this system has focused on the mechanisms of pathogenesis. We have found that this infection causes progressive loss of metabolic stores, similar to the wasting seen in people with tuberculosis. We have shown that, in the fly, this wasting effect is caused partly by systemic failures in anabolic signals via the insulin effector kinase Akt. We are now working to try to understand how infection causes this defect in anabolic signalling. We also have mutants that affect other aspects of disease; we are working with these mutants to understand other aspects of disease pathogenesis as well as how the fly immune system fights Mycobacterial infections.
Physiological control of metabolic balance
As mentioned above, we've found that infection with M marinum causes serious metabolic defects in Drosophila. At least some of these effects are due to changes in signalling pathways whose roles in metabolic control are largely unexplored or completely unknown. This has led us to examine the roles of these pathways in metabolic control in healthy animals so that we can then understand the effects of infection-induced perturbation of these pathways.
This work is preliminary but is very exciting - we hope to be able to say more soon!
Recent updates to the lab wiki
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
4 May 2024
| 18:10 | The Paper that Launched Microfluidics - Xi Ning diffhist −86 Xning098 talk contribs (→Electrokinetic effect) | ||||
| 11:36 | User:Jernej Turnsek diffhist +50 Jernej Turnsek talk contribs | ||||
|
|
09:20 | User:Massih Forootan 3 changes history +83 [Massih Forootan (3×)] | |||
|
|
09:20 (cur | prev) +78 Massih Forootan talk contribs (→Link to Publications) | ||||
|
|
09:18 (cur | prev) 0 Massih Forootan talk contribs (→Skills) | ||||
|
|
09:18 (cur | prev) +5 Massih Forootan talk contribs (→Skills) | ||||
|
|
07:28 | CHEM-ENG590E:Wiki Textbook 4 changes history −445 [Sarah L. Perry (4×)] | |||
|
|
07:28 (cur | prev) +84 Sarah L. Perry talk contribs (→Chapter 4 - Flow Control and Mixing) | ||||
|
|
07:21 (cur | prev) −490 Sarah L. Perry talk contribs (→Chapter 9 - Microfluidics and Cell Culture) | ||||
|
|
07:19 (cur | prev) −35 Sarah L. Perry talk contribs (→Chapter 9 - Microfluidics and Cell Culture) | ||||
|
|
07:18 (cur | prev) −4 Sarah L. Perry talk contribs (→Chapter 4 - Flow Control and Mixing) | ||||
| 07:18 | Move log Sarah L. Perry talk contribs moved page Microfluidic Gradient Generators - Greg Schneider to Microfluidic Gradient Generators (Adding an Author) | ||||
| 00:15 | Renhao Li Lab:Publications diffhist +265 Renhao Li talk contribs (→2024) | ||||
3 May 2024
| 15:02 | CHIP:Talks diffhist 0 Gabor Balazsi talk contribs | ||||
| 15:01 | CHIP:Data diffhist −23 Gabor Balazsi talk contribs | ||||
|
|
14:33 | UA Biophysics:Protocols:Kanamycin 5 changes history −421 [Elizabeth Suesca (5×)] | |||
|
|
14:33 (cur | prev) +13 Elizabeth Suesca talk contribs | ||||
|
|
14:21 (cur | prev) +16 Elizabeth Suesca talk contribs (→Materials) | ||||
|
|
14:19 (cur | prev) −6 Elizabeth Suesca talk contribs | ||||
|
|
14:14 (cur | prev) −50 Elizabeth Suesca talk contribs | ||||
|
|
14:13 (cur | prev) −394 Elizabeth Suesca talk contribs | ||||
|
|
14:33 | UA Biophysics:Protocols:Ampicillin 4 changes history −379 [Elizabeth Suesca (4×)] | |||
|
|
14:33 (cur | prev) +15 Elizabeth Suesca talk contribs | ||||
|
|
14:19 (cur | prev) −7 Elizabeth Suesca talk contribs | ||||
|
|
14:11 (cur | prev) 0 Elizabeth Suesca talk contribs (→PROTOCOL) | ||||
|
|
14:09 (cur | prev) −387 Elizabeth Suesca talk contribs | ||||
|
|
14:31 | UA Biophysics:Protocols:Erythromycin 3 changes history −315 [Elizabeth Suesca (3×)] | |||
|
|
14:31 (cur | prev) −7 Elizabeth Suesca talk contribs | ||||
|
|
14:30 (cur | prev) −12 Elizabeth Suesca talk contribs (→Materials) | ||||
|
|
14:18 (cur | prev) −296 Elizabeth Suesca talk contribs | ||||
|
|
14:29 | UA Biophysics:Protocols:Chloramphenicol 2 changes history −427 [Elizabeth Suesca (2×)] | |||
|
|
14:29 (cur | prev) +36 Elizabeth Suesca talk contribs | ||||
|
|
14:16 (cur | prev) −463 Elizabeth Suesca talk contribs | ||||
|
|
N 12:09 | BioMicroCenter:Oligo Synthesis 7 changes history +4,408 [Noelani Kamelamela (7×)] | |||
|
|
12:09 (cur | prev) −14 Noelani Kamelamela talk contribs (→Dr Oligo 96) | ||||
|
|
12:09 (cur | prev) −16 Noelani Kamelamela talk contribs (→STX-200) | ||||
|
|
12:08 (cur | prev) −46 Noelani Kamelamela talk contribs (→Dr Oligo 96) | ||||
|
|
12:08 (cur | prev) +35 Noelani Kamelamela talk contribs (→Dr Oligo 96) | ||||
|
|
08:29 (cur | prev) +7 Noelani Kamelamela talk contribs (→Dr Oligo 96) | ||||
|
|
08:27 (cur | prev) +59 Noelani Kamelamela talk contribs (→Dr Oligo 96) | ||||
| N |
|
08:16 (cur | prev) +4,383 Noelani Kamelamela talk contribs (Created page with "{{BioMicroCenter}} ''' ** All users must be trained before being allowed to use the equipment **'''<BR><BR> The BioMicro Center currently hosts two oligo synthesizers: one Dr Oligo 96 (Biolytic) and one Syntax STX-200 (DNAScript). <br><br> Dr Oligo is optimized for higher concentrations of oligos made through polyamidite synthesis. For ready to use oligos a series of steps must be completed using the other related machines in the Center including the column presser, the...") | |||
|
|
12:06 | BioMicroCenter:Covaris 5 changes history +172 [Noelani Kamelamela (5×)] | |||
|
|
12:06 (cur | prev) −5 Noelani Kamelamela talk contribs (→R230) | ||||
|
|
09:55 (cur | prev) +2 Noelani Kamelamela talk contribs (→R230) | ||||
|
|
09:54 (cur | prev) +1 Noelani Kamelamela talk contribs (→R230) | ||||
|
|
09:52 (cur | prev) +4 Noelani Kamelamela talk contribs (→R230) | ||||
|
|
08:41 (cur | prev) +170 Noelani Kamelamela talk contribs (→R230) | ||||
|
|
09:52 | (Upload log) [Noelani Kamelamela (6×)] | |||
|
|
09:52 Noelani Kamelamela talk contribs uploaded File:R230pic.jpg | ||||
|
|
08:42 Noelani Kamelamela talk contribs uploaded File:R230pic.jpeg | ||||
|
|
08:32 Noelani Kamelamela talk contribs uploaded File:Syntax.jpg | ||||
|
|
08:31 Noelani Kamelamela talk contribs uploaded File:Droligoprocess.jpg | ||||
|
|
08:29 Noelani Kamelamela talk contribs uploaded File:Chamber.jpg | ||||
|
|
08:28 Noelani Kamelamela talk contribs uploaded File:DrOligo.jpg | ||||
2 May 2024
|
|
19:54 | Paper Microfluidic Device for Archiving Breast Epithelial Cells 5 changes history −389 [Xning098 (5×)] | |||
|
|
19:54 (cur | prev) −10 Xning098 talk contribs (→Diseases tested with neonatal heel pricks) | ||||
|
|
19:53 (cur | prev) −12 Xning098 talk contribs (→Results with Breast Epithelial Cells) | ||||
|
|
19:49 (cur | prev) 0 Xning098 talk contribs (→Current diagnostic tools) | ||||
|
|
19:45 (cur | prev) +45 Xning098 talk contribs (→Design Parameters) | ||||
|
|
19:40 (cur | prev) −412 Xning098 talk contribs (→Design Parameters) | ||||
